Keyword Analysis & Research: biogen idec

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
biogen idec	1.77	0.4	8727	15	11
biogen	0.49	0.7	9279	52	6
idec	0.54	0.2	4544	50	4

Keyword	CPC	PCC	Volume	Score
biogen idec	0.87	0.3	8054	80
biogen idec stock	0.04	0.2	1006	17
biogen idec limited	0.57	1	9082	22
biogen idec research limited	1.75	0.8	2174	70
biogen idec gmbh	1.04	0.5	4410	67
biogen idec ma inc	0.89	0.8	5811	49
biogen idec careers	1.07	0.4	1997	7
biogen idec cambridge ma	1.52	0.8	7462	33
biogen idec company	1.2	0.1	5871	85
biogen idec pipeline	1.78	0.6	1492	82
biogen idec uk	1.76	0.5	3225	40
biogen idec ireland ltd	0.88	0.7	9883	94
biogen idec david weiner	1.93	0.2	9585	61
biogen idec inc	1.3	0.7	7636	68
biogen idec ltd	1.69	0.1	2448	100
biogen idec inc san diego	0.53	0.8	3178	43
imraldi + biogen idec ltd	1.19	0.1	4498	74
biogen idec jobs	0.24	0.4	5081	81
what is biogen idec	0.27	1	2915	37
classen immunotherapies inc. v. biogen idec	0.48	0.4	7718	21

Home | Biogen
biogen.com:443

https://www.biogen.com:443/

WEBBiogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through …

DA: 13 PA: 56 MOZ Rank: 1

Biogen IDEC - Home - Idec Pharma
idecpharm.com:80

http://www.idecpharm.com:80/site/home.html

WEBAug 19, 2022 · Biogen Idec invests in its employees. We offer challenges, learning and innovation along with a comprehensive compensation and benefits program. We invite you to join us.

DA: 66 PA: 11 MOZ Rank: 96

Biogen - Wikipedia
wikipedia.org:443

https://en.wikipedia.org:443/wiki/Biogen

WEBIn 2003, Biogen merged with San Diego, California-based IDEC Pharmaceuticals (formed in 1985 by University of California-San Diego's physicians and immunologists Ivor Royston and Robert E. Sobol, San Diego bio entrepreneur Howard Birndorf, and Stanford University cancer researchers Ron Levy and Richard Miller) and adopted the name Biogen Idec.

DA: 10 PA: 28 MOZ Rank: 92

Biogen Idec Becomes Biogen | Biogen
biogen.com:443

https://investors.biogen.com:443/news-releases/news-release-details/biogen-idec-becomes-biogen

WEBCAMBRIDGE, Mass.--(BUSINESS WIRE)--Effective today, Biogen Idec is known simply as Biogen (NASDAQ: BIIB). The company has introduced a new corporate identity and logo that reflect both its evolution and focus on bringing forth new therapies in areas of high unmet need – while honoring Biogen’s scientific heritage and legacy as a pioneer in ...

DA: 84 PA: 22 MOZ Rank: 41

Company | Biogen
biogen.com:443

https://www.biogen.com:443/company.html

WEBBiogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through …

DA: 2 PA: 63 MOZ Rank: 75

Biogen Inc. (BIIB) Stock Price, News, Quote & History - Yahoo Finance
yahoo.com:443

https://finance.yahoo.com:443/quote/BIIB/

WEBBiogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are...

DA: 55 PA: 25 MOZ Rank: 82

Biogen and IDEC Pharmaceuticals Announce Merger To Create …
idecpharm.com:80

http://www.idecpharm.com:80/news/pr_i006.html

WEBAug 18, 2022 · IDEC has a strong franchise in cancer and a growing focus on autoimmune diseases, while Biogen is strong in the autoimmune area and is increasingly developing capabilities in cancer. The merger is expected to enable the companies to: — achieve cumulative capital expenditure synergies of over $175 million through 2007.

DA: 8 PA: 83 MOZ Rank: 98

Samsung and Biogen Idec Announce Joint Venture to Develop, …
biogen.com:443

https://investors.biogen.com:443/news-releases/news-release-details/samsung-and-biogen-idec-announce-joint-venture-develop

WEBAbout Biogen Idec. Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology company.

DA: 68 PA: 67 MOZ Rank: 63

Biogen Idec to Expand Neuropathic Pain Portfolio with the …
biogen.com:443

https://investors.biogen.com:443/news-releases/news-release-details/biogen-idec-expand-neuropathic-pain-portfolio-acquisition

WEBJan 11, 2015 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Biogen Idec (NASDAQ: BIIB) announced today that it has agreed to acquire U.K.-based Convergence Pharmaceuticals, a clinical-stage biopharmaceutical company with an innovative portfolio of ion channel-modulating product candidates for neuropathic pain.

DA: 13 PA: 83 MOZ Rank: 83

Biogen Idec and Genentech Announce Restructuring of anti …
biogen.com:443

https://investors.biogen.com:443/news-releases/news-release-details/biogen-idec-and-genentech-announce-restructuring-anti-cd20

WEBOct 21, 2010 · Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients worldwide benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis.

DA: 21 PA: 34 MOZ Rank: 69